Trial Profile
Modulation of stress analgesia with tetrahydrocannabinol or cannabidiol
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary) ; Tetrahydrocannabinol (Primary)
- Indications Pain
- Focus Pharmacodynamics
- Acronyms LOGIN-TS4
- 09 Jan 2015 Status changed from not yet recruiting to completed.
- 05 Mar 2014 New trial record